腦膜瘤表達(dá)抗原5(MGEA5)重組蛋白
Recombinant Meningioma Expressed Antigen 5 (MGEA5)
NAGase; MEA5; NCOAT; Hexosaminidase C; N-Acetylhexosaminidase; Hyaluronidase; Meningioma-Expressed Antigen 5; Nuclear Cytoplasmic O-GlcNAcase And Acetyltransferase
- 編號(hào)RPA069Hu03
- 物種Homo sapiens (Human，人) 相同的名稱(chēng)，不同的物種。
- 來(lái)源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位細(xì)胞核, 細(xì)胞質(zhì)
- 預(yù)測(cè)分子量53.1kDa
- 實(shí)際分子量65kDa(差異分析請(qǐng)參閱說(shuō)明書(shū))
- 片段與標(biāo)簽Ser6~Thr450 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 80%
- 等電點(diǎn)4.6
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見(jiàn)活性蛋白。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 840 ¥ 2100 ¥ 4200 ¥ 12600 ¥ 31500
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. Gene Sequencing (Extract)
-
Figure. SDS-PAGE
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA069Hu03 | 腦膜瘤表達(dá)抗原5(MGEA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA069Hu01 | 腦膜瘤表達(dá)抗原5(MGEA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA069Hu02 | 腦膜瘤表達(dá)抗原5(MGEA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA069Hu03 | 腦膜瘤表達(dá)抗原5(MGEA5)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA069Hu01 | 腦膜瘤表達(dá)抗原5(MGEA5)多克隆抗體 | WB,IHC,ICC/IF |
| PAA069Hu02 | 腦膜瘤表達(dá)抗原5(MGEA5)多克隆抗體 | WB; IHC; ICC; IP. |
| FAA069Hu01 | 抗腦膜瘤表達(dá)抗原5(MGEA5)多克隆抗體 | Flow cytometry. |
| LAA069Hu71 | 腦膜瘤表達(dá)抗原5(MGEA5)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAA069Hu22 | 腦膜瘤表達(dá)抗原5(MGEA5)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA069Hu | 腦膜瘤表達(dá)抗原5(MGEA5)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA069Hu | 腦膜瘤表達(dá)抗原5(MGEA5)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA069Hu | 腦膜瘤表達(dá)抗原5(MGEA5)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Plos one | Metal-on-Metal Hip Prostheses and Systemic Health: A Cross-Sectional Association Study 8 Years after Implantation [PubMed: PMC3677913] |
| Renal Failure | Evaluation of the Process of Recycling and Renal Parenchymal Injury after ESWL with Metabolites Excreted in the Urine [Pubmed: 23413820] |
| BioMed Research International | The Renal Effects of Vanadate Exposure: Potential Biomarkers and Oxidative Stress as a Mechanism of Functional Renal Disorders—Preliminary Studies [Hindawi: 740105] |
| PLoS One | Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats [PubMed: 25909514] |
| Ecotoxicol Environ Saf | Melamine and oxalate coexposure induces early kidney tubular injury through mitochondrial aberrations and oxidative stress [34507040] |
| Antioxidants | Diminishment of Nrf2 Antioxidative Defense Aggravates Nephrotoxicity of Melamine and Oxalate Coexposure. Antioxidants 2021, 10, 1464 [34573096] |
留言咨詢(xún)
